M. Kokonozaki

Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V Leiden

M. Alexandrakis, A. Papadopoulou, N. Androulakis, 2015, Nephron.

Mast Cells Influence the Proliferation Rate of Myeloma Plasma Cells

M. Alexandrakis, G. Tsirakis, C. Pappa, 2015, Cancer investigation.

Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma

K. Sfiridaki, I. Neonakis, M. Alexandrakis, 2015, Journal of Cancer Research and Clinical Oncology.

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity

M. Alexandrakis, G. Tsirakis, A. Papadopoulou, 2015, Medical Oncology.

Clinical significance of interleukin-22 in multiple myeloma

I. Neonakis, M. Alexandrakis, G. Tsirakis, 2015, Hematology.

Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.

M. Tzardi, M. Alexandrakis, G. Tsirakis, 2015, Leukemia research.

Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple Myeloma.

M. Tzardi, M. Alexandrakis, G. Tsirakis, 2016, Clinical therapeutics.

High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity

A. Alegakis, M. Alexandrakis, A. Papadopoulou, 2015, Tumor Biology.